Entasis Therapeutics Holdings Inc

(NASDAQ:ETTX)

Latest On Entasis Therapeutics Holdings Inc (ETTX):

Date/Time Type Description Signal Details
2022-05-23 18:53 ESTNewsInnoviva to acquire Entasis Therapeutics for $2.20/shareN/A
2022-02-02 18:23 ESTNewsEntasis gains on buyout proposal from InnovivaN/A
2021-11-17 17:00 ESTNewsEntasis Therapeutics: AstraZeneca Spin-Out Developing Targeted Antibacterial ProductsN/A
2021-11-06 20:03 ESTNewsEntasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 08:31 ESTNewsEntasis Therapeutics EPS beats by $0.02N/A
2021-10-19 09:46 ESTNewsEntasis says primary endpoint met in late-stage trial for SUL-DUR in Acinetobacter infectionsN/A
2021-09-21 17:47 ESTNewsEntasis up 14% following publication on new antibiotic class drug candidateN/A
2021-08-12 16:44 ESTNewsEntasis Therapeutics EPS beats by $0.04N/A
2021-08-12 16:42 ESTNewsEntasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-27 09:26 ESTNewsZai Lab and Entasis complete enrollment in late-stage sulbactam-durlobactam studyN/A
2021-07-21 07:41 ESTNewsEntasis Therapeutics shares rise after lining up ETX0462 poster presentationN/A
2021-07-21 07:27 ESTNewsEntasis Therapeutics introduces ETX0462 targeting gram-negative and biothreat pathogensN/A
2021-05-06 11:26 ESTNewsEntasis Therapeutics EPS beats by $0.07N/A
2021-05-03 22:07 ESTNewsEntasis completes initial closing of $20M private placement with InnovivaN/A
2021-03-23 22:57 ESTNewsEntasis Therapeutics EPS beats by $0.30N/A
2020-11-26 19:56 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 11:42 ESTAnalyst RatingThe Analyst Target Price has increased from $6.08 to $6.5.Buy
2020-11-11 20:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 11:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 11:52 ESTAnalyst RatingThe Analyst Target Price has decreased from $6.5 to $6.08.Neutral
2020-11-07 15:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 07:52 ESTEarnings EstimateAn EPS average of -$0.41 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 07:51 ESTNewsEntasis Therapeutics EPS beats by $0.13N/A
2020-09-26 12:42 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:49 ESTFinancialsCompany financials have been released.Neutral
2020-09-09 20:37 ESTAnalyst RatingThe Analyst Target Price has decreased from $6.8 to $6.5.Neutral
2020-09-01 17:50 ESTInsider TradeInnoviva, Inc. has directly acquired 4,672,897 shares and currently holds 18,672,897 shares.Buy
2020-08-29 00:38 ESTNewsEntasis Therapeutics secures equity raise of $25MN/A
2020-08-14 08:44 ESTFinancialsCompany financials have been released.Neutral
2020-08-09 08:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 17:58 ESTNewsEntasis Therapeutics EPS misses by $0.04N/A
2020-07-31 00:56 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:57 ESTFinancialsCompany financials have been released.Neutral
2020-07-20 16:42 ESTAnalyst RatingThe Analyst Target Price has increased from $6.25 to $6.8.Buy
2020-07-09 08:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-07 07:39 ESTNewsEntasis Therapeutics nabs NIH contract for $3MN/A
2020-06-26 08:38 ESTFinancialsCompany financials have been released.Neutral
2020-06-25 11:33 ESTNewsEntasis Therapeutics (ETTX) Investor Presentation - SlideshowN/A
2020-06-12 19:01 ESTInsider TradeInnoviva, Inc. has directly acquired 12,677,490 shares and currently holds 14,000,000 shares.Buy
2020-06-12 04:41 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 16:49 ESTEarnings EstimateAn EPS average of -$0.58 is estimated for the quarter ending on September 30, 2020.Buy
2020-06-02 16:49 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.75 to $6.25.Neutral
2020-05-27 04:45 ESTFinancialsCompany financials have been released.Neutral
2020-05-10 00:44 ESTFinancialsCompany financials have been released.Neutral
2020-05-08 13:25 ESTNewsEntasis Therapeutics EPS misses by $0.15N/A
2020-05-06 04:47 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:48 ESTFinancialsCompany financials have been released.Neutral
2020-04-16 00:36 ESTAnalyst RatingThe Analyst Target Price has decreased from $14.5 to $9.75.Neutral
2020-04-11 14:12 ESTNewsEntasis Therapeutics EPS misses by $0.40, misses on revenueN/A
2020-04-11 14:04 ESTNewsEntasis Therapeutics up 181% amid Covid-19 frenzyN/A

About Entasis Therapeutics Holdings Inc (ETTX):

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant gram-negative bacteria in the United States. It is involved in developing Sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that has completed Phase II clinical trial for the treatment of multi-drug resistant Acinetobacter infections; Zoliflodacin, a novel orally administered molecule that has completed Phase II clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I clinical trial for the treatment of urinary tract infections; and ETX0462, a drug candidate from NBP platform that is in pre-clinical stage for the treatment of multidrug-resistant Gram-negative infections. The company has collaboration agreements with Zai Lab (Shanghai) Co., Ltd. for developing SUL-DUR. Entasis Therapeutics Holdings Inc. was incorporated in 2018 and is based in Waltham, Massachusetts.

ETTX Quotes by TradingView

See Advanced Chart

General

  • Name Entasis Therapeutics Holdings Inc
  • Symbol ETTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 48
  • Fiscal Year EndDecember
  • IPO Date2018-09-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.entasistx.com
View More

Valuation

  • Trailing PE 0.05
  • Price/Sales (Trailing 12 Mt.) 3.33
  • Price/Book (Most Recent Quarter) 1.67
  • Enterprise Value Revenue 1.29
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.46
  • Return on Assets -53%
  • Return on Equity -92%
  • Earnings Per Share -$3.33
  • Revenue Per Share $0
  • Gross Profit 7 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 100.04 million
  • Analyst Target Price $6.5
  • Book Value Per Share $1.75
View More

Share Statistics

  • Shares Outstanding 35.48 million
  • Shares Float 12.48 million
  • % Held by Insiders 5886%
  • % Held by Institutions 30.95%
  • Shares Short 181589
  • Shares Short Prior Month 193165
  • Short Ratio 0.44
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.99
  • 52 Week High $4.25
  • 52 Week Low $1.58
  • 50 Day Moving Average 3.02
  • 200 Day Moving Average 2.44
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Entasis Therapeutics Holdings Inc (ETTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Entasis Therapeutics Holdings Inc (ETTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$0.37-$0.4924.99%
2020-06-302020-08-06$N/A-$0.78-$0.73-6.24%
2020-03-312020-05-07$N/A-$1.15-$0.99-16.75%
2019-12-312020-03-11$N/A-$1.06-$0.65-63%
2019-09-302019-11-14$7 million-$0.27-$0.8367.52%
2019-06-302019-08-12$N/A-$1.02-$0.58-77.11%
2019-03-312019-05-14$N/A-$0.99-$0.53-85.22%
2018-12-312019-03-29$N/A-$1.31-$0.77-70.98%
2018-09-302018-11-14$-5000000-$1.34-$0.92-45.65%

Entasis Therapeutics Holdings Inc (ETTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Entasis Therapeutics Holdings Inc (ETTX) Chart:

Entasis Therapeutics Holdings Inc (ETTX) News:

Below you will find a list of latest news for Entasis Therapeutics Holdings Inc (ETTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Entasis Therapeutics Holdings Inc (ETTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest ETTX Trades:

Date Shares Price
Jun 13, 2022 6:26 PM EST600$2.19
Jun 13, 2022 6:26 PM EST1$2.19
Jun 13, 2022 6:29 PM EST200$2.19
Jun 13, 2022 6:29 PM EST300$2.19
Jun 13, 2022 6:29 PM EST500$2.19

Entasis Therapeutics Holdings Inc (ETTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312520172130/0001193125-20-172130-index.htm
2019-10-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1724344/000000000019014404/0000000000-19-014404-index.htm
2020-08-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1724344/000000000020007322/0000000000-20-007322-index.htm
2020-04-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000089914020000256/0000899140-20-000256-index.htm
2020-06-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000089914020000297/0000899140-20-000297-index.htm
2020-08-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000089914020000388/0000899140-20-000388-index.htm
2020-09-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000089914020000390/0000899140-20-000390-index.htm
2019-01-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000089924319001173/0000899243-19-001173-index.htm
2018-09-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000090342318000522/0000903423-18-000522-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000090342318000527/0000903423-18-000527-index.htm
2018-10-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000090342318000541/0000903423-18-000541-index.htm
2020-09-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724344/000091957420005723/0000919574-20-005723-index.htm
2018-09-26424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1724344/000104746918006439/0001047469-18-006439-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1724344/000104746919002752/0001047469-19-002752-index.htm
2019-10-02S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1724344/000104746919005552/0001047469-19-005552-index.htm
2019-10-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1724344/000104746919005820/0001047469-19-005820-index.htm
2020-05-05PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1724344/000104746920002810/0001047469-20-002810-index.htm
2020-05-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1724344/000104746920003095/0001047469-20-003095-index.htm
2018-10-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000107261318000503/0001072613-18-000503-index.htm
2018-09-25S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1724344/000110465918058516/0001104659-18-058516-index.htm
2018-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465918059431/0001104659-18-059431-index.htm
2018-10-05SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000110465918060726/0001104659-18-060726-index.htm
2018-10-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000110465918061736/0001104659-18-061736-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465918068265/0001104659-18-068265-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724344/000110465918068460/0001104659-18-068460-index.htm
2018-11-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1724344/000110465918068487/0001104659-18-068487-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465919002743/0001104659-19-002743-index.htm
2019-03-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919018464/0001104659-19-018464-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465919025277/0001104659-19-025277-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1724344/000110465919025308/0001104659-19-025308-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465919035218/0001104659-19-035218-index.htm
2019-06-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919036995/0001104659-19-036995-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919037000/0001104659-19-037000-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919037002/0001104659-19-037002-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919037004/0001104659-19-037004-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919037005/0001104659-19-037005-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919037006/0001104659-19-037006-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919037008/0001104659-19-037008-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465919037193/0001104659-19-037193-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465919044292/0001104659-19-044292-index.htm
2019-08-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919044297/0001104659-19-044297-index.htm
2019-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919044300/0001104659-19-044300-index.htm
2019-10-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1724344/000110465919054013/0001104659-19-054013-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465919055102/0001104659-19-055102-index.htm
2019-11-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919060493/0001104659-19-060493-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465919060495/0001104659-19-060495-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920003273/0001104659-20-003273-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920007113/0001104659-20-007113-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920007115/0001104659-20-007115-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920007116/0001104659-20-007116-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920007117/0001104659-20-007117-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920007119/0001104659-20-007119-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920007120/0001104659-20-007120-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920007122/0001104659-20-007122-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920045695/0001104659-20-045695-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920049780/0001104659-20-049780-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1724344/000110465920049781/0001104659-20-049781-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920053329/0001104659-20-053329-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920064730/0001104659-20-064730-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920072391/0001104659-20-072391-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920072400/0001104659-20-072400-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920086001/0001104659-20-086001-index.htm
2020-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1724344/000110465920091489/0001104659-20-091489-index.htm
2020-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1724344/000110465920093769/0001104659-20-093769-index.htm
2020-08-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1724344/000110465920095654/0001104659-20-095654-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920096886/0001104659-20-096886-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920101460/0001104659-20-101460-index.htm
2020-09-10DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920103896/0001104659-20-103896-index.htm
2020-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920104439/0001104659-20-104439-index.htm
2020-10-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1724344/000110465920112217/0001104659-20-112217-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920112657/0001104659-20-112657-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920112659/0001104659-20-112659-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920112660/0001104659-20-112660-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000110465920112661/0001104659-20-112661-index.htm
2020-10-13424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1724344/000110465920114352/0001104659-20-114352-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000110465920122481/0001104659-20-122481-index.htm
2018-10-10SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000114420418053072/0001144204-18-053072-index.htm
2018-10-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724344/000119312518289658/0001193125-18-289658-index.htm
2018-10-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312518295225/0001193125-18-295225-index.htm
2018-12-24SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312518356778/0001193125-18-356778-index.htm
2019-01-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312519006220/0001193125-19-006220-index.htm
2020-01-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312520006070/0001193125-20-006070-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724344/000119312520025135/0001193125-20-025135-index.htm
2020-03-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312520082433/0001193125-20-082433-index.htm
2020-05-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312520131110/0001193125-20-131110-index.htm
2020-06-16SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724344/000119312520170205/0001193125-20-170205-index.htm
2020-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312520172130/0001193125-20-172130-index.htm
2020-07-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1724344/000119312520190493/0001193125-20-190493-index.htm
2020-08-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724344/000119312520216367/0001193125-20-216367-index.htm
2018-09-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118052239/0001209191-18-052239-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118052485/0001209191-18-052485-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118052486/0001209191-18-052486-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118052489/0001209191-18-052489-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118052498/0001209191-18-052498-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118052499/0001209191-18-052499-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118052791/0001209191-18-052791-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118053533/0001209191-18-053533-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118053534/0001209191-18-053534-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118053535/0001209191-18-053535-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118053536/0001209191-18-053536-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118053537/0001209191-18-053537-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118053538/0001209191-18-053538-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118053539/0001209191-18-053539-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118053540/0001209191-18-053540-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919118064107/0001209191-18-064107-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004765/0001209191-19-004765-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004766/0001209191-19-004766-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004767/0001209191-19-004767-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004768/0001209191-19-004768-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004770/0001209191-19-004770-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004771/0001209191-19-004771-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004772/0001209191-19-004772-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004773/0001209191-19-004773-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004774/0001209191-19-004774-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119004776/0001209191-19-004776-index.htm
2019-04-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119026591/0001209191-19-026591-index.htm
2019-04-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919119026607/0001209191-19-026607-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000120919120003162/0001209191-20-003162-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837019002587/0001558370-19-002587-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1724344/000155837019002588/0001558370-19-002588-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837019002793/0001558370-19-002793-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837019004958/0001558370-19-004958-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724344/000155837019004959/0001558370-19-004959-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837019007938/0001558370-19-007938-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724344/000155837019007940/0001558370-19-007940-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837019010985/0001558370-19-010985-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724344/000155837019010989/0001558370-19-010989-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837020002404/0001558370-20-002404-index.htm
2020-03-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1724344/000155837020002414/0001558370-20-002414-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1724344/000155837020004627/0001558370-20-004627-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1724344/000155837020004632/0001558370-20-004632-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837020005720/0001558370-20-005720-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724344/000155837020005745/0001558370-20-005745-index.htm
2020-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1724344/000155837020005764/0001558370-20-005764-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837020009651/0001558370-20-009651-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724344/000155837020009666/0001558370-20-009666-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1724344/000155837020009692/0001558370-20-009692-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1724344/000155837020012868/0001558370-20-012868-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1724344/000155837020012889/0001558370-20-012889-index.htm
2020-04-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000156761920008352/0001567619-20-008352-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000156761920012108/0001567619-20-012108-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1724344/000156761920016247/0001567619-20-016247-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1724344/000158064219000777/0001580642-19-000777-index.htm
2018-09-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1724344/999999999518002450/9999999995-18-002450-index.htm
2019-10-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1724344/999999999519002336/9999999995-19-002336-index.htm
2020-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1724344/999999999520002159/9999999995-20-002159-index.htm
2020-10-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1724344/999999999520002833/9999999995-20-002833-index.htm
2018-09-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1724344/999999999718008208/9999999997-18-008208-index.htm
2018-09-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1724344/999999999718008210/9999999997-18-008210-index.htm

Entasis Therapeutics Holdings Inc (ETTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Entasis Therapeutics Holdings Inc (ETTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 5886%
Institutional Ownership: 3095%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-28TPG Group Holdings (SBS) Advisors, Inc.InsiderBuy262,539.0015.003,938,085.001,020,748.00https://www.sec.gov/Archives/edgar/data/1724344/000090342318000527/0000903423-18-000527-index.htm
2018-12-21Ruben TommasiChief Scientific OfficerBuy11,788.003.7444,087.1211,788.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118064107/0001209191-18-064107-index.htm
2018-09-28Heather PrestonDirectorBuy337,724.0015.005,065,860.001,180,178.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118053538/0001209191-18-053538-index.htm
2018-09-28Pivotal bioVenture Partners Fund I, L.P.10% Share HolderBuy337,724.0015.005,065,860.001,180,178.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118053537/0001209191-18-053537-index.htm
2018-09-28Sofinnova Venture Partners IX, L.P.10% Share HolderBuy337,724.0015.005,065,860.001,180,178.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118053539/0001209191-18-053539-index.htm
2020-01-09Frazier Life Sciences VIII, L.P.10% Share HolderSell50,000.005.00250,010.001,299,953.00https://www.sec.gov/Archives/edgar/data/1724344/000120919120003162/0001209191-20-003162-index.htm
2018-09-28Frazier Life Sciences VIII, L.P.10% Share HolderBuy375,887.0015.005,638,305.001,349,953.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118053535/0001209191-18-053535-index.htm
2018-09-28James N TopperDirectorBuy375,887.0015.005,638,305.001,349,953.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118053540/0001209191-18-053540-index.htm
2020-06-11Innoviva, Inc.10% Share HolderBuy12,677,490.002.5031,693,725.0014,000,000.00https://www.sec.gov/Archives/edgar/data/1724344/000156761920012108/0001567619-20-012108-index.htm
2018-09-28Clarus Lifesciences III, L.P.10% Share HolderBuy453,395.0015.006,800,925.001,623,405.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118053534/0001209191-18-053534-index.htm
2018-09-28NICHOLAS GALAKATOSDirectorBuy453,395.0015.006,800,925.001,623,405.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118053536/0001209191-18-053536-index.htm
2020-09-01Innoviva, Inc.10% Share HolderBuy4,672,897.002.6812,499,999.4818,672,897.00https://www.sec.gov/Archives/edgar/data/1724344/000156761920016247/0001567619-20-016247-index.htm
2018-09-28PLC ASTRAZENECA10% Share HolderBuy246,666.0015.003,699,990.002,164,855.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118053533/0001209191-18-053533-index.htm
2018-09-28Holdings A/S Novo10% Share HolderBuy1,089,835.0015.0016,347,525.002,181,843.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118052791/0001209191-18-052791-index.htm
2018-12-21Ruben TommasiChief Scientific OfficerBuy10,236.003.1131,833.9622,024.00https://www.sec.gov/Archives/edgar/data/1724344/000120919118064107/0001209191-18-064107-index.htm